MoneyWorks4Me

Sequent Scientific informs about transcript of earnings call

13 Nov 2023 Evaluate

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. The same is also available on the Company’s website at https://www.sequent.in/pdf/financial/2023- 2024/Sequent%20Transcript_Nov07_2023.pdf.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..